Table 1. The relations between CUL4B and clinicopathologic characteristics of BC patients.
Influence factor | Case | CUL4B | P | |
---|---|---|---|---|
High expression | Low expression | |||
Age | 0.601 | |||
< 65 | 83 | 49 | 34 | |
≧ 65 | 59 | 38 | 21 | |
Gender | 0.69 | |||
Male | 107 | 67 | 40 | |
Female | 35 | 20 | 15 | |
TNM Stage | 0.015 | |||
I-II | 59 | 29 | 30 | |
III-IV | 83 | 58 | 25 | |
Lymph node metastasis | 0.005 | |||
N0-N1 | 58 | 27 | 31 | |
N2-N3 | 84 | 60 | 24 | |
Myometrial invasion | 0.001 | |||
T1-T2 | 75 | 36 | 39 | |
T3-T4 | 67 | 51 | 16 |
TNM, tumor-node-metastasis; BC, bladder cancer.